Stavick 40 Capsule contains Stavudine 40mg, a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment and management of HIV infection. It helps in reducing viral replication and improving immune system function in patients living with HIV.
Stavudine works by blocking the reverse transcriptase enzyme, which prevents the virus from multiplying and supports sustained suppression of HIV. This ensures better long-term management of the infection.
This capsule is commonly prescribed as part of combination antiretroviral therapy (ART), providing effective viral control and convenient oral administration to improve patient adherence during chronic treatment regimens.
For PCD pharma franchise partners, Stavick 40 Capsule is a high-demand antiretroviral product, available at best price for PCD pharma franchise, making it suitable for hospitals, clinics, pharmacies, and export markets. Its strong clinical demand and prescriber confidence make it a strategic addition to any HIV care portfolio.
Common side effects may include nausea, diarrhea, headache, fatigue, or mild abdominal discomfort. Rare but serious side effects include peripheral neuropathy, lactic acidosis, pancreatitis, liver toxicity, or severe allergic reactions. Immediate medical attention is required if severe symptoms occur.
Stavick 40 Capsule is indicated for the treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy, as prescribed by a healthcare professional.
Stavick 40 Capsule should be taken exactly as prescribed, usually in combination with other antiretroviral drugs. Regular monitoring of liver function, blood counts, and viral load is recommended. Inform the doctor of any history of liver or kidney disease, neuropathy, or any concurrent medications.
Store Stavick 40 Capsule in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.